Position in NSRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$471,698
+$172,507 QoQ
Shares Held
134,771
0.0% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 10 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. NSRX ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in NSRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $471,698 | 134,771 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $299,191 | 134,771 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||